Loading...

Hydroxyurea for sickle cell anemia: What have we learned and what questions still remain?

PURPOSE OF REVIEW: Sickle cell anemia (SCA) is a well-characterized severe hematological disorder with substantial morbidity and early mortality. Hydroxyurea is a potent inducer of fetal hemoglobin, and evidence over the past 25 years has documented its laboratory and clinical efficacy for both adul...

Full description

Saved in:
Bibliographic Details
Main Authors: McGann, Patrick T., Ware, Russell E.
Format: Artigo
Language:Inglês
Published: 2011
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3181131/
https://ncbi.nlm.nih.gov/pubmed/21372708
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOH.0b013e32834521dd
Tags: Add Tag
No Tags, Be the first to tag this record!